Sign Up to like & get
recommendations!
0
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-140202
Abstract: Introduction: ABL tyrosine kinase inhibitors (TKIs) improved outcomes for patients with chronic myeloid leukemia (CML) and Philadelphia chromosome (Ph)-positive leukemia. However, ABL TKIs do not eliminate the leukemia stem cells (LSCs) in the bone marrow,…
read more here.
Keywords:
abl tki;
hypoxic condition;
treatment;
chs828 ... See more keywords